Biochemical Pharmacology

Uptake and mode of action of drugs used against sleeping sickness
pp. 1-5(5)
Authors: Denise H.; Barrett M.P.

Inhibitory effects of ruthenium red on inositol 1,4,5-trisphosphate-induced responses in rat megakaryocytes
pp. 7-13(7)
Authors: Ikeda M.; Maruyama Y.

Prevention of c-Jun/activator protein-1 activation and microsomal epoxide hydrolase induction in the rat liver by cysteine during protein-calorie malnutrition
pp. 15-24(10)
Authors: Cho M.K.; Kim Y.G.; Lee M.G.; Kim S.G.

Signaling pathways leading to the induction of ornithine decarboxylase: Opposite effects of p44/42 mitogen-activated protein kinase (MAPK) and p38 MAPK inhibitors
pp. 25-32(8)
Authors: Flamigni F.; Facchini A.; Giordano E.; Tantini B.; Stefanelli C.

Suppression of cell cycle progression by a fungal lectin: activation of cyclin-dependent kinase inhibitors
pp. 33-37(5)
Authors: Liua W.-k.; Ho J.C.K.; Ng T.-b.

Reduced cellular transport and activation of fluoropyrimidine nucleosides and resistance in human lymphocytic cell lines selected for arabinosylcytosine resistance
pp. 39-47(9)
Authors: Agarwal R.P.; Han T.; Fernandez M.

Cell cycle phase specificity in the potentiation of etoposide-induced DNA damage and apoptosis by KN-62, an inhibitor of calcium-calmodulin-dependent enzymes
pp. 49-54(6)
Authors: Aoyama M.; Grabowski D.R.; Holmes K.A.; Rybicki L.A.; Bukowski R.M.; Ganapathi M.K.; Ganapathi R.

Structure-activity relationships of neurokinin A (4-10) at the human tachykinin NK₂ receptor: the role of natural residues and their chirality
pp. 55-60(6)
Authors: Warner F.J.; Mack P.; Comis A.; Miller R.C.; Burcher E.

Characterization of multidrug transporters in a normal renal tubular cell line resistant to doxorubicin - Multidrug transporters in the LLC-PK₁ cell line and its resistant counterpart
pp. 61-66(6)
Authors: Decorti G.; Rosati A.; Candussio L.; Giraldi T.; Bartoli Klugmann F.

Does the antitumor cyclopropylpyrroloindole antibiotic CC-1065 cross-link DNA in tumor cells?
pp. 67-72(6)
Authors: Skladanowski A.; Koba M.; Konopa J.

Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidants
pp. 73-85(13)
Authors: dos Santos El-Bacha R.; Daval J.-L.; Koziel V.; Netter P.; Minn A.

Differential regulation of protein tyrosine kinase on free radical production, granule enzyme release, and cytokine synthesis by activated murine peritoneal macrophages
pp. 87-96(10)
Authors: Kim Y.K.; Jang Y.Y.; Kim D.H.; Ko H.H.; Han E.S.; Lee C.S.

Pharmacological profile of F 12511, (S)-2',3',5'-trimethyl-4'-hydroxy--dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor
pp. 97-108(12)
Authors: Junquero D.; Oms P.; Carilla-Durand E.; Autin J.-M.; Tarayre J.-P.; Degryse A.-D.; Patoiseau J.-F.; Colpaert F.C.; Delhon A.

Potentiation by aminoethylisothiourea of the extra-cellular Ca²⁺ component of norepinephrine-induced contraction in rat femoral arteries
pp. 109-118(10)
Authors: Martnez M.C.; Randriamboavonjy V.; Stoclet J.-C.; Andriantsitohaina R.

Prevention of human smooth muscle cell proliferation without induction of apoptosis by the topoisomerase I inhibitor topotecan
pp. 119-127(9)
Authors: Brehm B.R.; Bock C.; Wesselborg S.; Pfeiffer S.; Schuler S.; Schulze-Osthoff K.